Trelstar

(Triptorelin pamoate)

Trelstar

Drug updated on 11/17/2023

Dosage FormInjection (intramuscular: 3.75 mg, 11.25 mg, 22.5 mg)
Drug ClassGonadotropin releasing hormone (GnRH) agonist
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the treatment of advanced prostate cancer.

Product Monograph / Prescribing Information

Document TitleYearSource
Trelstar (triptorelin pamoate) Prescribing Information.2023Verity Pharmaceuticals, Inc., Ewing, NJ

Systematic Reviews / Meta-Analyses